Mechanism identified of impaired dendritic cell function that weakens response to cancer

The mechanism implicated in the defective function of tumor-associated dendritic cells (DCs), a specialized type of immune cells that expose the antigens on their surface to activate the T cells, has now been revealed by researchers.